Literature DB >> 12388993

Impaired tolerance for glucose in women with recurrent vaginal candidiasis.

Gilbert G G Donders1, Hans Prenen, Geert Verbeke, Reinhilde Reybrouck.   

Abstract

OBJECTIVE: The purpose of this study was to determine whether nondiabetic women with recurrent vaginal candidiasis have an impaired glucose metabolism. STUDY
DESIGN: A case-control study of 62 otherwise healthy women who were attending a vaginitis clinic > or =3 times a year for symptoms of Candida vaginitis, positive microscopy, and at least one positive Candida culture and of 32 Candida-negative control subjects, all of whom were undergoing standardized oral glucose tolerance testing.
RESULTS: Women with recurrent bacterial vaginal infections did not differ from women without infections, so both groups comprised the control group. Women with recurrent vaginal candidiasis had a greater mean body mass index than the control subjects (23.5 vs 21.4, P =.001). They had no more incidences of overt or preclinical diabetes mellitus than the control subjects (6/62 vs 0/32 incidents), but a greater proportion of them had at least one glucose concentration above the 95th percentile (36% vs 12%, P =.016). Glucose concentrations were higher in recurrent vaginal candidiasis cases than in control subjects at 0 (89 vs 85 mg/dL,P =.049), 30 (139 vs 126 mg/dL, P =.05), and 60 minutes (123 vs 102 mg/dL, P =.009) after the intake of 75 g of glucose. Fasting concentration of glycosylated hemoglobin was 25% higher in women with recurrent vaginal candidiasis (5 vs 4 g/dL, P =.0006), even after correction for body mass index. Compared with control subjects, ingestion of 75 g of glucose led to a 15% increase of serum glucose levels in women with recurrent vaginal candidiasis (P =.01). As expected, most of these differences were largely mediated by an increased body mass index.
CONCLUSION: The tolerance to glucose in nondiabetic women with recurrent vaginal candidiasis is discretely impaired. Glucose tolerance testing is of value in women with recurrent vaginal candidiasis, but the interpretation of the obtained values should not be limited to the diagnosis of preclinical diabetes mellitus.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12388993     DOI: 10.1067/mob.2002.126285

Source DB:  PubMed          Journal:  Am J Obstet Gynecol        ISSN: 0002-9378            Impact factor:   8.661


  12 in total

1.  Vulvovaginal Candidosis (excluding chronic mucocutaneous candidosis). Guideline of the German Society of Gynecology and Obstetrics (AWMF Registry No. 015/072, S2k Level, December 2013).

Authors:  W Mendling; K Friese; I Mylonas; E-R Weissenbacher; J Brasch; M Schaller; P Mayser; I Effendy; G Ginter-Hanselmayer; H Hof; O Cornely; M Ruhnke
Journal:  Geburtshilfe Frauenheilkd       Date:  2015-04       Impact factor: 2.915

2.  Vulvovaginal Candidosis (Excluding Mucocutaneous Candidosis): Guideline of the German (DGGG), Austrian (OEGGG) and Swiss (SGGG) Society of Gynecology and Obstetrics (S2k-Level, AWMF Registry Number 015/072, September 2020).

Authors:  Alex Farr; Isaak Effendy; Brigitte Frey Tirri; Herbert Hof; Peter Mayser; Ljubomir Petricevic; Markus Ruhnke; Martin Schaller; Axel P A Schäfer; Birgit Willinger; Werner Mendling
Journal:  Geburtshilfe Frauenheilkd       Date:  2021-04-14       Impact factor: 2.915

3.  Sodium choleate (NaCho) effects on Candida albicans: implications for its role as a gastrointestinal tract inhabitant.

Authors:  Bao Vu; Michael Essmann; Bryan Larsen
Journal:  Mycopathologia       Date:  2009-10-30       Impact factor: 2.574

4.  The role of Human Dectin-1 Y238X Gene Polymorphism in recurrent vulvovaginal candidiasis infections.

Authors:  Betul Usluogullari; Ilknur Gumus; Esra Gunduz; Ikbal Kaygusuz; Serap Simavli; Muradiye Acar; Murat Oznur; Mehmet Gunduz; Hasan Kafali
Journal:  Mol Biol Rep       Date:  2014-07-10       Impact factor: 2.316

5.  Highlights Regarding Host Predisposing Factors to Recurrent Vulvovaginal Candidiasis: Chronic Stress and Reduced Antioxidant Capacity.

Authors:  Luciene Akimoto-Gunther; Patrícia de Souza Bonfim-Mendonça; Gisele Takahachi; Mary Mayumi T Irie; Sônia Miyamoto; Márcia Edilaine Lopes Consolaro; Terezinha I Estivalet Svidzinsk
Journal:  PLoS One       Date:  2016-07-14       Impact factor: 3.240

6.  Vulvovaginal Candidiasis in Aminu Kano Teaching Hospital, North-West Nigeria: Hospital-Based Epidemiological Study.

Authors:  E A Ugwa
Journal:  Ann Med Health Sci Res       Date:  2015 Jul-Aug

7.  RISK FACTORS OF VULVOVAGINAL CANDIDIASIS IN DERMATO-VENEREOLOGY OUTPATIENTS CLINIC OF SOETOMO GENERAL HOSPITAL, SURABAYA, INDONESIA.

Authors:  Dharin Serebrina Arfiputri; Afif Nurul Hidayati; Samsriyaningsih Handayani; Evy Ervianti
Journal:  Afr J Infect Dis       Date:  2018-03-07

8.  Glucose tolerance in pregnant women with vaginal candidiasis.

Authors:  Sefa Kelekci; Handan Kelekci; Meltem Cetin; Ismet Inan; Selma Tokucoglu
Journal:  Ann Saudi Med       Date:  2004 Sep-Oct       Impact factor: 1.526

Review 9.  A meta-analysis of the relationship between vaginal microecology, human papillomavirus infection and cervical intraepithelial neoplasia.

Authors:  Yuejuan Liang; Mengjie Chen; Lu Qin; Bing Wan; He Wang
Journal:  Infect Agent Cancer       Date:  2019-10-26       Impact factor: 2.965

Review 10.  Vulvovaginal Candidosis: Current Concepts, Challenges and Perspectives.

Authors:  Valentina Sustr; Philipp Foessleitner; Herbert Kiss; Alex Farr
Journal:  J Fungi (Basel)       Date:  2020-11-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.